Saudi lymphoma group's clinical practice guidelines for diagnosis, management and follow-up of patients with various types of lymphoma during the Coronavirus Disease 2019 pandemic
Musa Alzahrani1, Mubarak M Al-Mansour2, John Apostolidis3, Ahmed Barefah4, Reyad Dada5, Ayman Alhejazi6, Yasir Alayed7, Ibraheem Motabi8, Mansoor Radwi9, Hani Al-Hashmi3
1 Department of Medicine and Oncology Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia 2 Department of Medicine, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah; Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Dammam, Saudi Arabia 3 Department of Adult Hematology and Stem Cell Transplantation, Oncology Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia 4 Department of Hematology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia 5 Department of Oncology, King Faisal Specialist Hospital and Research Centre, Jeddah; Department of Medicine, College of Medicine, Al-Faisal University, Riyadh, Saudi Arabia 6 Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia 7 Radiation Oncology, College of Medicine, King Saud University, Riyadh, Saudi Arabia 8 Department of Adult Hematology and BMT, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia 9 Department of Hematology, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia
Correspondence Address:
Dr. Musa Alzahrani Department of Medicine, College of Medicine, King Khalid University Hospital, P.O. Box: 7805, Riyadh 11472 DEM 65 Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/sjmms.sjmms_457_20
|